Company Information
About Ixion
Products
Management expand tree
Financial Info
Shareholder Info expand tree
SEC/Finance Reports
Target Diseases
  Diabetes General Information
  Diabetes FAQ's
  Diabetes Economic Impact
  Diabetes Product Plan
  Diabetes Questions/Comments
  Kidney Stones
  Cystic Fibrosis
  Crohn's Disease
  Primary Hyperoxaluria
  Idiopathic Hyperoxaluria
  Vulvodynia
  Catheters & Stents
Questions/Comments
  Aspergillosis
  Companion (Animal)
Inside Ixion
          Scientific Articles
          Intellectual Property
Newsroom
          2003
          2002
          2001
Contact Us
   Online Form/Contact Info
   Directions & Map
Home 
2001 Press Releases   Subscribe to our E-Mail List for future Press Releases

New NIH Grant Brings Ixion Closer to Developing Treatment for Kidney Stones
October 02, 2001

Ixion's Director of Research Joins American Diabetes Association Research Grant
Review Panel
September 21, 2001

Q-Med Makes Final Payment to Ixion Biotechnology
July 30, 2001

Håkan S. Edstrom Joins Ixion Board
July 24, 2001

Ixion, World Leader in Oxalate-related Disease Technology, Secures Two More Patents
June 18, 2001

Ixion Awarded $500,000 Phase II NIH Grant to Further Develop Treatment For Hyperoxaluric Conditions, Such as Kidney Stones
June 01, 2001

Ixion Names Kessler VP Corporate Development
January 01, 2001


Press releases, in reverse chronological order and are a historical archive only. The posting of press releases in this archive shall not, under any circumstances, create any impression that the information contained in press releases is correct as of any time subsequent to the date thereof, or that there has been no change in our affairs since such date.